Jeffrey S Dome Selected Research

Jeffrey S Dome Research Topics

Disease

54	Neoplasms (Cancer) 10/2022 - 02/2002
41	Wilms Tumor (Wilm's Tumor) 10/2022 - 02/2002
8	Neoplasm Metastasis (Metastasis) 01/2021 - 10/2004
5	Osteosarcoma (Osteogenic Sarcoma) 01/2015 - 05/2002
4	Anaplasia 01/2020 - 01/2014
4	Renal Cell Carcinoma (Grawitz Tumor) 01/2019 - 04/2006
3	Leukemia 04/2022 - 04/2007
2	Nausea 04/2022 - 12/2020
2	Vomiting 04/2022 - 12/2020
2	Pleuropulmonary blastoma 12/2020 - 09/2014
2	Neuroblastoma 12/2020 - 12/2007
2	Medullary Carcinoma 12/2020 - 01/2018
2	Melanoma (Melanoma, Malignant) 01/2020 - 10/2019
2	Rhabdoid Tumor (Rhabdoid Tumors) 09/2014 - 05/2006
2	Thrombosis (Thrombus) 04/2012 - 05/2008
2	Rare Diseases (Rare Disease) 07/2011 - 11/2003
2	Pleural Effusion (Pleural Effusions) 12/2007 - 02/2004
2	Carcinogenesis 03/2003 - 09/2002
1	Lymphoma (Lymphomas) 04/2022
1	Hematologic Neoplasms (Hematological Malignancy) 01/2022
1	Infertility (Sterility) 01/2022
1	Thrombocytopenia (Thrombopenia) 11/2021
1	Recurrent respiratory papillomatosis 08/2021
1	Pain (Aches) 01/2021
1	Hypoxia (Hypoxemia) 01/2021
1	Fever (Fevers) 01/2021
1	Fistula 12/2020
1	Synovial Sarcoma (Synovioma) 12/2020
1	Rhabdomyosarcoma 12/2020
1	Neurofibrosarcoma (MPNST) 12/2020
1	Hyperglycemia 12/2020
1	WAGR Syndrome (Syndrome, WAGR) 01/2020
1	Aniridia 01/2020
1	Sickle Cell Trait 01/2019
1	Hemoglobinopathies 01/2019
1	Carcinoma (Carcinomatosis) 01/2018
1	Tuberous Sclerosis (Bourneville's Disease) 01/2018
1	Intestinal Obstruction (Obstruction, Intestinal) 10/2015
1	Breast Neoplasms (Breast Cancer) 12/2014

Drug/Important Bio-Agent (IBA)

7	Vincristine (Oncovin)FDA LinkGeneric 01/2021 - 10/2012
6	DNA (Deoxyribonucleic Acid)IBA 10/2019 - 09/2002
5	Biological ProductsIBA 01/2021 - 05/2003
5	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2020 - 05/2002
5	Dactinomycin (Actinomycin)FDA LinkGeneric 01/2019 - 10/2012
5	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2015 - 09/2004
4	Proteins (Proteins, Gene)FDA Link 01/2019 - 12/2006
4	Messenger RNA (mRNA)IBA 10/2017 - 09/2004
3	NucleotidesIBA 10/2022 - 04/2007
3	Irinotecan (Camptosar)FDA LinkGeneric 11/2021 - 02/2006
3	Pharmaceutical PreparationsIBA 01/2019 - 06/2010
2	Biomarkers (Surrogate Marker)IBA 10/2022 - 01/2017
2	AntigensIBA 01/2022 - 10/2019
2	SurvivinIBA 01/2022 - 10/2019
2	Succinate Dehydrogenase (Fumarate Reductase)IBA 12/2020 - 01/2018
2	Etoposide (VP 16)FDA LinkGeneric 10/2020 - 05/2002
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2020 - 05/2002
2	MicroRNAs (MicroRNA)IBA 10/2017 - 02/2015
2	Indicators and Reagents (Reagents)IBA 02/2013 - 12/2005
2	OligonucleotidesIBA 03/2009 - 06/2007
2	EnzymesIBA 04/2007 - 09/2004
1	Circulating Tumor DNAIBA 10/2022
1	Ondansetron (Zofran)FDA LinkGeneric 04/2022
1	Alkylating AgentsIBA 01/2022
1	Sorafenib (BAY 43-9006)FDA Link 11/2021
1	Topoisomerase I InhibitorsIBA 11/2021
1	Lipase (Acid Lipase)FDA Link 11/2021
1	Tyrosine Kinase InhibitorsIBA 11/2021
1	Bevacizumab (Avastin)FDA Link 08/2021
1	AntibodiesIBA 01/2021
1	Carrier Proteins (Binding Protein)IBA 01/2021
1	EchinomycinIBA 01/2021
1	lorvotuzumab mertansineIBA 12/2020
1	Alanine Transaminase (SGPT)IBA 12/2020
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 12/2020
1	Polytetrafluoroethylene (Teflon)FDA Link 12/2020
1	Carboplatin (JM8)FDA LinkGeneric 10/2020
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2020
1	Tumor Biomarkers (Tumor Markers)IBA 01/2019
1	ProhibitinsIBA 01/2019
1	ProteomeIBA 01/2019
1	Fumarate Hydratase (Fumarase)IBA 01/2018
1	Transcription Factors (Transcription Factor)IBA 01/2018
1	Microphthalmia-Associated Transcription FactorIBA 01/2018
1	Anaplastic Lymphoma KinaseIBA 01/2018
1	17- (dimethylaminoethylamino)- 17- demethoxygeldanamycinIBA 01/2015
1	imetelstatIBA 01/2015
1	Amino Acids FDA Link 09/2014

Therapy/Procedure

31	Therapeutics 04/2022 - 02/2002
27	Drug Therapy (Chemotherapy) 04/2022 - 03/2002
18	Nephrectomy 01/2020 - 02/2004
9	Radiotherapy 01/2022 - 01/2014
2	Thrombectomy 01/2013 - 05/2008
2	Adjuvant Chemotherapy 11/2009 - 11/2005
1	Transplantation 01/2022
1	Salvage Therapy 01/2022
1	Precision Medicine 01/2021
1	Immunotherapy 10/2019
1	Ligation 10/2016
1	Secondary Prevention 12/2014
1	Central Venous Catheters 10/2014